Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) (N-Term) Peptide
ILF2
Reactivity: Human, Mouse
Host: Synthetic
BP, WB
-
- Target See all ILF2 products
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
- Protein Region
- N-Term
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- KRNQDLAPNS AEQASILSLV TKINNVIDNL IVAPGTFEVQ IEEVRQVGSY
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Ilf2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
- Background
-
Ilf2 appears to function predominantly as a heterodimeric complex with ILF3. This complex may regulate transcription of the IL2 gene during T-cell activation. It can also promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA.
Alias Symbols: 6230405A16Rik, TEG-267, Tex261, Tex267
Protein Size: 390 - Molecular Weight
- 42 kDa
- Gene ID
- 67781
- NCBI Accession
- NM_026374, NP_080650
- UniProt
- Q9CXY6
-
You are here:
